Circulating tumor DNA sequencing analysis of patients with metastatic renal cell carcinoma (mRCC).
Zengin Z, Dizman N, Salgia N, Jones J, Zhang J, Liu Y, Xu B, Li F, Wang Y, Li M, Du R, Zhou Y, Hsu J, Salgia M, Yang L, Pal S. Circulating tumor DNA sequencing analysis of patients with metastatic renal cell carcinoma (mRCC). Journal Of Clinical Oncology 2020, 38: e17100-e17100. DOI: 10.1200/jco.2020.38.15_suppl.e17100.Peer-Reviewed Original ResearchMetastatic renal cell carcinomaRelevant genomic alterationsRenal cell carcinomaGenomic alterationsCell carcinomaPathway alterationsCtDNA next-generation sequencingLines of therapyClear cell histologyMTOR pathway alterationsRate of concordanceCell histologyMedian ageSingle institutionTreatment sequencingClinicopathologic variablesCancer DatabaseCtDNA assessmentInvasive approachUrine specimenBlood specimensCtDNA studiesPatient databasePathogenic alterationsTumor DNA